UNSPSC 85893644: Low dose rate (ldr) brachytherapy of bladder using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of bladder using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DT12B9Z

UNSPSC 85893644 Low dose rate brachytherapy of bladder using iodine 125, a Commodity code, shows little relevant recent state and local procurement activity. The single recent opportunity tagged to this code—a County of Santa Clara Health System RFQ for temporary health professional staffing services posted July 7, 2026, with responses due October 7, 2026—involves general ancillary clinical staffing (audiology, cardiology, diagnostic imaging, gastroenterology, respiratory care, sterile processing, surgical services, and therapy services) and bears no connection to specialized radiation oncology treatment protocols or brachytherapy services as the code nominally describes. The mismatch suggests either a tagging error or that the code is not actively used by state and local procurement offices for actual brachytherapy procurement.

Without additional recent opportunities aligned to the code's stated scope, no reliable geographic concentration, issuing-body pattern, or market signal can be drawn. The Santa Clara Health System opportunity, while large in scope as a multiple-award qualified vendor pool with potential five-year duration, addresses general temporary clinical staffing rather than the specialized oncology equipment, physics consulting, or treatment-planning services that a brachytherapy code would typically capture. Firms pursuing state and local work in cancer treatment or radiation oncology should confirm whether relevant opportunities appear under higher-tier Family or Class codes covering oncology services or diagnostic imaging, or monitor whether brachytherapy procurement shifts to explicit specialized codes as state health systems modernize their contracting taxonomies.